About
Sergio Ruiz is the Co-founder and Managing Director of Methuselah Fund, a seed-stage mission-oriented venture fund investing in companies extending healthy human lifespan, and a co-founder and COO of Turn Biotechnologies, a Stanford spinout developing mRNA reprogramming therapies to reverse aging. He also serves as Executive Advisor to the Methuselah Foundation and is a board member at Leucadia Therapeutics. With 10+ years of non-profit management experience and membership in Methuselah Foundation's elite 'The 300' donor cohort, Ruiz sits at the intersection of longevity philanthropy and commercial biotech investment.
Areas of interest
longevityaging reversalbiotechgerosciencecell reprogrammingsenolytic therapieslife sciencesseed-stage deep techmission-driven investing